Notify Me
ZYVIEON HEALTHCARE PVT LTD

STEOMIN OS Tablet 10's

MRP ₹189.00 (Inclusive of all taxes)
New Reduced MRP as per revised GST benefit.
Deliver to

    Netmeds First Membership

    Starting at just ₹[] for 3 months.
    View Plans

    Introduction About STEOMIN OS TABLET

    Steomin OS Tablet is a dietary supplement that is used for the management of bone health. It contains Calcium Orotate, Folic Acid, Levocarnitine, Magnesium Hydroxide, Methylcobalamin, Vitamin D3, and Zinc as active ingredients which helps to maintain strong bones and muscles, are important for bone mineralization and bone matrix formation, and helps to maintain bone mass.

    Calcium orotate protects the calcium from stomach acid which allows it to remain intact and facilitates its movement towards intestines. Folic acid helps in the production and maintenance new red blood cells. Levocarnitine has an influence on bone density. Magnesium Hydroxide promotes new bone formation. Methylcobalamin is an important component for nerve health, and brain function.

    Vitamin D3 enhances calcium absorption and bone mineralization. Zinc is essential for normal skeletal growth and bone homeostasis. It also promotes bone regeneration. Take Steomin OS Tablet as advised by your doctor. It should be taken with water, do not crush or chew the tablet. Take one to two tablets during the day. Do not exceed the recommended intake. It is not recommended to take Steomin OS Tablet in patients with hypercalcemia.

    Steomin OS Tablet should be used with caution in patients with phenylketonuria, renal disorders, renal lithiasis, achlorhydria (where the stomach does not produce hydrochloric acid), malabsorption syndrome, and sarcoidosis (abnormal collections of inflammatory cells that form lumps).

    Key Composition

    • Calcium Orotate
    • Folic Acid
    • Levocarnitine
    • Magnesium Hydroxide
    • Methylcobalamin
    • Vitamin D3
    • Zinc

    Author Details

    Written By Dr. Priyanka Goel - BDS
    Reviewed For Accuracy By Dr. Shruthi Raikar - BDS
    Last updated on 13 Apr 2023 | 05:15 PM(IST)
    Lab updated